Charlotte’s Gift

Charlotte’s Gift is a high-CBD, low-THC cannabis strain developed specifically for therapeutic applications, named after Charlotte Figi, a young girl whose severe epilepsy responded dramatically to CBD-rich cannabis treatment. The strain was created by the Stanley Brothers, Colorado-based cannabis breeders who pioneered the development of CBD-dominant cultivars in response to growing medical interest in cannabidiol's potential benefits. Charlotte’s Gift represents one of the foundational strains in the medical cannabis movement that brought CBD to mainstream attention, particularly for pediatric epilepsy cases that were unresponsive to conventional treatments.

This sativa-dominant cultivar is characterized by its exceptionally high CBD-to-THC ratio, typically ranging from 20:1 to 30:1, making it non-intoxicating while providing the therapeutic benefits associated with cannabidiol. The plants exhibit classic sativa characteristics with tall, slender structures, narrow leaves, and elongated flowering colas. The buds are typically light to medium green with occasional orange pistils and a moderate coating of trichomes. The strain's development marked a significant shift in cannabis breeding priorities, moving beyond THC potency to focus on specific cannabinoid profiles for medical applications.

Charlotte’s Gift gained international recognition following media coverage of Charlotte Figi's story, which helped catalyze legislative changes and increased research into CBD's medical potential. While originally bred for epilepsy treatment, the strain has become popular among medical cannabis patients seeking relief from various conditions without psychoactive effects. Its development represents an important milestone in the medical cannabis industry, demonstrating how targeted breeding could create cultivars with specific therapeutic profiles. The strain continues to be valued for its consistent high-CBD production and reliable therapeutic effects.